Time Restricted Eating in Sleep Apnea
Part of paid clinical trials in La Jolla, California.
- Sponsor
- University of California, San Diego
- Study ID
- NCT06047496
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Obstructive Sleep Apnea
- Time Restricted Eating
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Time restricted eating — BEHAVIORALCaloric intake restricted to a self-defined 8-10 hour window in each 24-hour period.
Study Details
Obstructive sleep apnea (OSA) is a highly prevalent disorder that is associated with both cardiovascular and metabolic dysfunction, such as hypertension, increased blood glucose levels and diabetes, obesity, and nonalcoholic fatty liver. While continuous positive airway pressure (CPAP), the best available OSA treatment, has been shown to improve blood pressure in OSA, it does not appear to improve metabolic consequences of OSA, and other therapies for OSA-induced dysmetabolism are needed. Animal models of time restricted eating (TRE) demonstrate an improvement in glucose and lipid metabolism, even in the absence of a reduction of caloric intake. Some human studies have shown an improvement in metabolic dysfunction with TRE, though further well-designed studies are needed. The effects of TRE on metabolic dysfunction in patients with OSA, a population with a high predisposition to metabolic disorder, has never been examined. In this study, we will conduct a randomized clinical trial to assess the feasibility and efficacy of 12 weeks of TRE, versus standard eating (SE), to improve glucose regulation and cardiovascular health of participants with OSA.
Key Dates
- Start date
- Jan 5, 2024
- Status verified
- Jan 2024
- Primary completion
- Jul 31, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Time restricted eatingCaloric intake restricted to a self-defined 8-10 hour window in each 24-hour period, for 12 weeks.
- No Intervention: Standard eatingNormal eating schedule. Participants are expected to maintain their normal eating and dietary habits.
Primary Outcome Measure
Effect of TRE vs SE on change in mean daily glucose level [ Time Frame: 12 weeks ]
Central Contacts
- Pamela DeYoung, RPSGT(858) 246-2154
- Omar Mesarwi, MD(858) 822-1783
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California San Diego (ACTRI) | La Jolla | California | 92037 |
Find similar trials in La Jolla, CA
Related Studies
- Magnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and SafetyRecruiting · Michael Harrison · San Francisco, California
- Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)Recruiting · Children's Hospital Los Angeles · Los Angeles, California
- Do Endotypes Predict Response and Sequelae in OSA PatientsPHASE2 · Recruiting · University of California, San Diego · La Jolla, California
- OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment UnitRecruiting · VA Office of Research and Development · San Diego, California